Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.490
+0.100 (7.19%)
Nov 22, 2024, 4:00 PM EST - Market closed
Evaxion Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 8 | 26 | 43 | 102 | - | - | |
| Market Cap Growth | -24.74% | -39.34% | -58.12% | - | - | - | |
| Enterprise Value | 4 | 23 | 27 | 94 | - | - | |
| Last Close Price | 1.49 | 6.86 | 17.75 | 44.20 | - | - | |
| PS Ratio | 2.09 | 355.98 | - | - | - | - | |
| PB Ratio | 111.26 | -5.50 | 5.16 | 3.15 | - | - | |
| P/TBV Ratio | 234.34 | - | 5.16 | 3.16 | - | - | |
| EV/Sales Ratio | 1.13 | 320.29 | - | - | - | - | |
| Debt / Equity Ratio | - | -2.30 | 1.24 | 0.11 | 0.00 | 0.00 | |
| Asset Turnover | 0.24 | 0.00 | - | - | - | - | |
| Quick Ratio | - | 0.94 | 3.85 | 7.88 | 1.63 | 6.09 | |
| Current Ratio | - | 1.18 | 4.51 | 8.03 | 2.22 | 6.36 | |
| Return on Equity (ROE) | - | -1238.11% | -113.74% | -124.29% | -183.15% | -265.57% | |
| Return on Assets (ROA) | -69.45% | -79.47% | -50.78% | -61.95% | -89.85% | -69.29% | |
| Return on Capital (ROIC) | -246.40% | -112.34% | -57.75% | -74.78% | -125.85% | -79.25% | |
| Earnings Yield | -137.90% | -85.14% | -54.08% | -23.98% | - | - | |
| FCF Yield | -68.41% | -60.85% | -22.71% | - | - | |
| Buyback Yield / Dilution | -78.19% | -15.64% | -21.27% | -26.29% | -11.10% | -7.55% | |
| Total Shareholder Return | -78.19% | -15.64% | -21.27% | -26.29% | -11.10% | -7.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.